Morningside Group is an investment firm that was founded in 1986 and is based in Hong Kong, Hong Kong. The firm makes private equity and venture capital investments in the information technology, life sciences and clean technology sectors. It also participates in philanthropic activities to enable education, support science and fund medical research.
Morningside Group was founded by the Chan family of Hong Kong. The Chan family founded the Hang Lung Group in 1960. Today, the Hang Lung Group consists of Hang Lung Group Limited [0010.HK] and Hang Lung Properties Limited [0101.HK]. Both companies are listed on the Hong Kong Stock Exchange. Hang Lung Properties Limited is a constituent stock of the Hang Seng Index.
Morningside Group invests in private equity and venture capital opportunities in North America, Europe and Asia Pacific. Since 1992, China has increasingly become a significant part of the group's investment activities. Morningside Group has investments in the following sectors -- machinery manufacturing, high-tech, media, telecommunication, life science, education and clean technology. The group is managed by experienced investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate.
A company developing immunotherapy treatments for cancers, infectious and autoimmune diseases
A biopharmaceutical company developing T cell vaccines and immunotherapies
A company developing antibacterial therapeutics for drug-resistant bacterial infections
A biotechnology company using microbiology and chemistry to produce consumer goods and industrial products.
Developing gene therapies to potentially cure rare diseases.
A company that provides cell and tissue based diagnostic tests for personalized medicine development
A company developing and manufacturing genome wide research and diagnostic products
Liquidia Technologies is a Durham, North Carolina-based nanotechnology company.
A company developing antiviral medicines for the treatment of diseases
A company developing tissue oximetry technology for measuring local tissue oxygen saturation
A company developing antibiotics to treat Gram-positive and Gram-negative infections
A drug discovery and development company focused on treating cancer with small molecule drugs
A biopharmaceutical company developing RNAi delivery technologies targeting infectious human diseases
A biotechnology company specializing in drug discovery contract research
Associated investment funds